Article
Medicine, Research & Experimental
Katarzyna Kuncewicz, Magdalena Bojko, Claire Battin, Agnieszka Karczynska, Adam Sieradzan, Emilia Sikorska, Katarzyna Wegrzyn, Karolina Wojciechowicz, Anna Wardowska, Peter Steinberger, Sylwia Rodziewicz-Motowidlo, Marta Spodzieja
Summary: Immune checkpoints are molecular pathways that regulate T cell activation and effector functions. Blockade of co-inhibitory pathways mediated by immune checkpoints is a strategy used to treat cancer. CTLA-4/CD80/CD86 and PD-1/PD-L1 are two main pathways being investigated, and monoclonal antibodies targeting them have shown immunomodulatory effects in clinical settings. BTLA/HVEM complex is another interesting target, and BTLA-derived peptides have potential as future drugs.
BIOMEDICINE & PHARMACOTHERAPY
(2023)
Article
Oncology
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. Gonzalez-Rodriguez, Angel R. Payer, Esther Gonzalez-Garcia, Alejandro Lopez-Soto, Segundo Gonzalez
Summary: Chronic lymphocytic leukemia (CLL) is characterized by progressive immunosuppression and resistance to targeted therapies. In this study, dysregulated expression of BTLA and HVEM in CLL patients was linked to poor outcomes. BTLA blockade restored NK cell-mediated responses, suggesting BTLA/HVEM axis as a potential therapeutic target in CLL.
Review
Biochemistry & Molecular Biology
Asma 'a H. Mohamed, Ruaa Ali Obeid, Ali Abdulhussain Fadhil, Ahmed Ali Amir, Zainab H. Adhab, Enaam Anad Jabouri, Irfan Ahmad, Mohammad Y. Alshahrani
Summary: Immunotherapy, particularly immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment. The discovery of the BTLA/HVEM checkpoint and its significant role in various malignancies provides opportunities for advancing cancer treatment through immunotherapy.
Review
Biochemistry & Molecular Biology
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Rocio Granda-Diaz, Alejandra Martinez-Perez, Candelaria Aguilar-Garcia, Juan P. Rodrigo, Juana M. Garcia-Pedrero, Segundo Gonzalez
Summary: The introduction of monoclonal antibodies targeting immune checkpoints has greatly impacted cancer treatment. However, limited overall responses and the lack of predictive biomarkers for patient response are major challenges in immunotherapy. Therefore, it is important to identify novel targets for immunotherapy to expand the range of strategies and improve therapeutic efficacy for cancer patients.
Article
Biochemistry & Molecular Biology
Katarzyna Kuncewicz, Claire Battin, Katarzyna Wegrzyn, Adam Sieradzan, Anna Wardowska, Emilia Sikorska, Irma Giedrojc, Pamela Smardz, Michal Pikula, Peter Steinberger, Sylwia Rodziewicz-Motowidlo, Marta Spodzieja
Summary: Cancer immunotherapy using blockade of immune checkpoints has achieved success, but antibodies have weaknesses, so finding alternative compounds is necessary. This study focused on designing peptides to disrupt the BTLA/HVEM complex and identified two peptides that interact with HVEM and possess blocking capacities, indicating their potential as immunomodulation agents for future cancer immunotherapy.
BIOORGANIC CHEMISTRY
(2022)
Article
Immunology
Yanbo Kou, Xingping Zheng, Liyuan Meng, Mengnan Liu, Shihong Xu, Qiyue Jing, Shenghan Zhang, Hanying Wang, Jinzhi Han, Zhuanzhuan Liu, Yanxia Wei, Yugang Wang
Summary: HVEM and BTLA deficiencies exacerbate liver injury and impair liver repair, potentially due to impaired neutrophil accumulation after injury. HVEM and BTLA deficiencies affect hepatic neutrophil accumulation and may restrain liver injury by regulating gut microbiota.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Cell Biology
Karolina Wojciechowicz, Marta Spodzieja, Katarzyna A. Lisowska, Anna Wardowska
Summary: Autoimmune diseases involve the loss of immune tolerance towards autoantigens. Understanding the pathogenesis and developing effective treatments are still ongoing areas of research. Immune checkpoints, particularly the BTLA-HVEM complex, have shown potential as important regulators in various immune contexts, including autoimmunity. The complex has mainly been studied in the context of cancer but may also be a target for treating autoimmune diseases.
CELLULAR IMMUNOLOGY
(2022)
Article
Cell Biology
Tian-You Cheng, Ya-Juan Liu, Hong Yan, Yi-Bo Xi, Li-Qiang Duan, Yang Wang, Tian-Tian Zhang, Yin-Min Gu, Xiao-Dong Wang, Chang-Xin Wu, Shan Gao
Summary: BTLA is an immune checkpoint molecule that is expressed across a broad range of tumor cells, and its overexpression inhibits tumor cell proliferation and colony formation. In contrast, the depletion of BTLA promotes cell growth. The coordination of BTLA and its ligand HVEM inhibits the ERK1/2 signaling pathway, thus preventing tumor cell growth.
Article
Immunology
Maryam Azarafza, Mohsen Tehrani, Reza Valadan, Iradj Maleki, Seyed Mohammad Mehdi Ghaffari-Hamedani, Alireza Ghanadan, Reza Alizadeh-Navaei, Abolghasem Ajami
Summary: This research investigated the expression of B- and T-lymphocyte attenuator (BTLA) / herpesvirus entry mediator (HVEM) in the development of gastric cancer. The results showed that BTLA mRNA and protein were significantly increased in advanced stages of gastric cancer, while HVEM was higher only at the protein level. The concentration of soluble HVEM (sHVEM) was also higher in the gastric cancer group compared to the control group. The study suggests that the BTLA/HVEM/sHVEM inhibitory pathway is involved in immune regulation and progression of gastric cancer.
Article
Biology
Chunbo Zhang, Tianyu Zhong, Yuanyuan Li, Xianfeng Li, Xiaopeng Yuan, Linlin Liu, Weilin Wu, Jing Wu, Ye Wu, Rui Liang, Xinhua Xie, Chuanchuan Kang, Yuwen Liu, Zhonghong Lai, Jianbo Xiao, Zhixian Tang, Riqun Jin, Yan Wang, Yongwei Xiao, Jin Zhang, Jian Li, Qian Liu, Zhongsheng Sun, Jianing Zhong
Summary: TET1 interacts with SIRT1 to regulate hepatic gluconeogenic gene expression, and the AMPK-TET1-SIRT1 axis plays a role in promoting glucose metabolism.
Review
Chemistry, Medicinal
Jinah Yeo, Minkyung Ko, Dong-Hee Lee, Yoon Park, Hyung-seung Jin
Summary: Although immune checkpoint blockade therapies have shown efficacy in multiple cancer indications, only a subset of patients benefit from them, highlighting the need for new approaches. TIGIT and CD226, as regulators of immune cells, have potential applications in cancer immunotherapy as they act on different pathways to modulate immune responses.
Article
Pharmacology & Pharmacy
Huiling Hu, Nannan Sun, Haiyan Du, Yuqing He, Kunyi Pan, Xiuli Liu, Xiaoxia Lu, Jie Wei, Mianmian Liao, Chaohui Duan
Summary: Previous studies have shown that PLZF plays a role in promoting gluconeogenic gene expression, hepatic glucose output, and consequent hyperglycemia. However, its role in regulating lipid metabolism was unknown. This study revealed that PLZF is an essential regulator of hepatic lipid and glucose metabolism. Overexpression of PLZF in the liver led to fatty liver, inflammation, impaired glucose tolerance, and insulin sensitivity. Knockdown of PLZF in obese mice alleviated hepatic steatosis. The underlying mechanism involved PLZF activating SREBP-1c gene transcription by binding to its promoter fragment, which depended on its interaction with SIRT1 to induce a repressor-to-activator conversion. These findings suggest that modulating PLZF expression in the liver could be a potential therapeutic approach for treating NAFLD.
FRONTIERS IN PHARMACOLOGY
(2022)
Review
Immunology
Huayu Guan, Xiang Zhang, Ming Kuang, Jun Yu
Summary: The gut-liver axis plays a crucial role in host-microbiota communications and immune homeostasis. In diseases such as hepatic cirrhosis, gut dysbiosis and impaired intestinal barrier lead to immune alterations in the liver and other organs. This review discusses the immune changes in the gut-liver axis and how microbiota-derived immune remodeling contributes to the progression of hepatic cirrhosis.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Zoology
Ying Wang, Hua-Min Wang, Yan Zhou, Ling-Hong Hu, Jing-Ming Wan, Ji-Hui Yang, Hong-Bo Niu, Xiu-Ping Hong, Peng Hu, Liang-Biao Chen
Summary: Pathways that regulate redox homeostasis in the most thermosensitive tissue, such as gills, may have a significant impact on determining the thermal tolerance limit of zebrafish.
ZOOLOGICAL RESEARCH
(2023)
Article
Medicine, Research & Experimental
Byungtae Hwang, Min-Gi Kwon, Min Ji Cho, Nam-Kyung Lee, Jangwook Lee, Jeong Woong Lee, Kyoung-Jin Oh, Kwang-Hee Bae, Jung Hwan Hwang, Jeong-Ki Min, Jong-Gil Park
Summary: This study highlights the critical role of PTP4A1 in regulating hepatosteatosis and glucose homeostasis. It demonstrates that PTP4A1 prevents the accumulation of hepatic lipids and regulates glucose uptake by activating the CREBH/FGF21 axis. Modulating PTP4A1 may offer a potential therapeutic strategy against hepatosteatosis-related diseases.
Article
Fisheries
Tong Shao, Lv-Yun Zhu, Li Nie, Wei Shi, Wei-Ren Dong, Li-Xin Xiang, Jian-Zhong Shao
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
(2015)
Article
Immunology
Tong Shao, Wei Shi, Jia-yu Zheng, Xiao-xiao Xu, Ai-fu Lin, Li-xin Xiang, Jian-zhong Shao
FRONTIERS IN IMMUNOLOGY
(2018)
Article
Immunology
Jun-xia Ma, Jiang-yuan Li, Dong-dong Fan, Wei Feng, Ai-fu Lin, Li-xin Xiang, Jian-zhong Shao
FRONTIERS IN IMMUNOLOGY
(2018)
Article
Immunology
Jiang-yuan Li, Ke Gao, Tong Shao, Dong-dong Fan, Chong-bin Hu, Cen-cen Sun, Wei-ren Dong, Ai-fu Lin, Li-xin Xiang, Jian-zhong Shao
JOURNAL OF IMMUNOLOGY
(2018)
Article
Biochemistry & Molecular Biology
Jiang-Yuan Li, Yue-Yi Wang, Tong Shao, Dong-Dong Fan, Ai-Fu Lin, Li-Xin Xiang, Jian-Zhong Shao
JOURNAL OF BIOLOGICAL CHEMISTRY
(2020)
Article
Oncology
Haoyan Li, Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Wei Shi, Chenling Meng, Jie Zhang, Kaitlyn Tremble, Xin Liang, Jian H. Song, Xu Feng, Vivien Van, Pingna Deng, Jared K. Burks, Ana Aparicio, Khandan Keyomarsi, Junjie Chen, Yue Lu, Himisha Beltran, Di Zhao
Summary: This study highlights the critical role of CHD1 in controlling Aurora kinase activation and promoting sensitivity to Aurora kinase inhibitors. It provides a potential clinical biomarker for predicting drug response in cancer treatment.
Article
Multidisciplinary Sciences
Jian Lu, Raheel Ahmad, Thomas Nguyen, Jeffrey Cifello, Humza Hemani, Jiangyuan Li, Jinguo Chen, Siyi Li, Jing Wang, Achouak Achour, Joseph Chen, Meagan Colie, Ana Lustig, Christopher Dunn, Linda Zukley, Chee W. Chia, Irina Burd, Jun Zhu, Luigi Ferrucci, Nan-Ping Weng
Summary: The decline of CD8(+) T cell functions with aging is a significant health issue, and this study uses single-cell RNA sequencing and machine learning to understand the mechanisms and predict the age of individual cells. This research has important implications for predicting functional outcomes in vaccination or infection.
NATURE COMMUNICATIONS
(2022)
Article
Cell Biology
Wei Shi, Yin Wang, Yuehui Zhao, Justin Jimin Kim, Haoyan Li, Chenling Meng, Feiyu Chen, Jie Zhang, Duncan H. Mak, Vivien Van, Javier Leo, Brad St Croix, Ana Aparicio, Di Zhao
Summary: B7-H3 is an immune checkpoint molecule in prostate tumors and its association with PTEN and TP53 genetic inactivation plays a critical role in cancer progression. Inhibition of B7-H3 combined with blockade of PD-L1 or CTLA-4 can lead to durable antitumor effects and cure potential. These findings provide valuable insights into the development of B7-H3-targeted immunotherapies and diagnostic biomarkers.
SCIENCE TRANSLATIONAL MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Cen-Cen Sun, Wei-Ren Dong, Tong Shao, Jiang-Yuan Li, Jing Zhao, Li Nie, Li-Xin Xiang, Guan Zhu, Jian-Zhong Shao
BIOCHEMICAL JOURNAL
(2017)